 |
This article relies excessively on referencestoprimary sources. Please improve this article by adding secondary or tertiary sources.
Find sources: "2C-F" – news · newspapers · books · scholar · JSTOR (December 2007) (Learn how and when to remove this message) |
 | |
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H14FNO2 |
| Molar mass | 199.225 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
2C-F (4-fluoro-2,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 250 mg.[1] 2C-F may be found as a brownish freebase oil, or as a white crystalline hydrochloride salt.
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-F[where?].
At a dose of 250 milligrams, 2C-F produces modest closed-eye visuals accompanied by lethargy.[1]
As of October 31, 2016, 2C-F is a controlled substance (Schedule III) in Canada.[2]
